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Abstract
The development of cellular tracking by fluorine (19F) magnetic resonance imaging (MRI) has introduced a number of
advantages for following immune cell therapies in vivo. These include improved signal selectivity and a possibility to
correlate cells labeled with fluorine-rich particles with conventional anatomic proton (1H) imaging. While the optimization of
the cellular labeling method is clearly important, the impact of labeling on cellular dynamics should be kept in mind. We
show by 19F MR spectroscopy (MRS) that the efficiency in labeling cells of the murine immune system (dendritic cells) by
perfluoro-15-crown-5-ether (PFCE) particles increases with increasing particle size (560.365.245.130 nm). Dendritic cells
(DC) are professional antigen presenting cells and with respect to impact of PFCE particles on DC function, we observed that
markers of maturation for these cells (CD80, CD86) were also significantly elevated following labeling with larger PFCE
particles (560 nm). When labeled with these larger particles that also gave an optimal signal in MRS, DC presented whole
antigen more robustly to CD8+ T cells than control cells. Our data suggest that increasing particle size is one important
feature for optimizing cell labeling by PFCE particles, but may also present possible pitfalls such as alteration of the
immunological status of these cells. Therefore depending on the clinical scenario in which the 19F-labeled cellular vaccines
will be applied (cancer, autoimmune disease, transplantation), it will be interesting to monitor the fate of these cells in vivo
in the relevant preclinical mouse models.
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Introduction
The prospect of being able to non-invasively track immune cells
in vivo is not only fascinating for scientists studying the pathogenesis
of autoimmune conditions such as multiple sclerosis or rheumatoid
arthritis but also for clinical researchers administering immune cell
therapies such as dendritic cell vaccines in cancer trials [1]. One
key consideration that is often neglected in clinical studies dealing
with cellular therapy is the rate of cell delivery and distribution,
which highly depends on the fate and function of the transplanted
cells. Originally, clinically applied cells such as dendritic cells (DC)
were monitored using scintigraphic scanning with radioactive
111In [2], although one major drawback with this imaging
technique is the lack of anatomical detail. Cellular tracking in
combination with 1H magnetic resonance imaging (MRI)
overcomes this drawback. Proton (1H) MRI employs spin physics
to determine water content and therefore properties of tissue
which makes this technique valuable to uncover anatomical as well
as any underlying pathophysiological details. Cellular MRI has
commonly been performed using T2*-weighted 1H imaging with
superparamagnetic small iron-oxide (SPIO) nanoparticles [3].
Non-invasive tracking of cells by MRI should prove to be an
important complement within the fields of cancer, autoimmunity
and transplantation medicine. However, the available susceptibil-
ity contrast agents such as the SPIO nanoparticles often make it
difficult for MRI scientists to differentiate the labeled cellular
transplants from other susceptibility-related T2* effects such as
paramagnetic deoxygenated blood [4]. An MRI technology using
fluorine (19F)-rich nanoparticles makes it possible to track 19F-
labeled cells very selectively in vivo [5]. Fluorine is distinct from any
other NMR (nuclear magnetic resonance)-active atom. Its
negligible endogenous presence in the body provides essentially
a 19F background free signal. As a consequence to this, as well as
the possibility of overlaying cellular 19F images with anatomic 1H
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images, 19F-MRI provides an important counterpart to 1H-MRI.
The potential applications for 19F-rich compounds in magnetic
resonance spectroscopy (MRS) and MRI have long been recognized
[6–8]. Fluorine compounds that are commonly used in biomedical
applications are chemically inert and synthetically derived per-
fluorocarbons (PFCs) that consist primarily of carbon and fluorine
atoms. These fluorine-rich compounds are insoluble in water and
must therefore be emulsified for clinically relevant applications such
as intravenous, intraperitoneal or intraparenchymal injections. The
particles obtained by emulsification typically have a size of
approximately 200 nm. The size of the PFC particles employed in
recent studies to label cells for in vivo 19F-MRI tracking ranged from
100 nm to 230 nm [5,9–11]. Although nanotechnologists define
nanoparticles as particles smaller than 100 nm [12], the definition is
dynamic in the biological sciences, commonly referring to particles
even up to 500 nm.
Increasing evidence suggests that the physico-chemical proper-
ties of nanoparticles determine the extent of their capacity to
modulate the immune system [12]. In the present study we aimed
to identify the outcome of changing the size of perfluoro-15-
crown-5-ether (PFCE) particles on their uptake by dendritic cells
(DC) and therefore the labeling efficiency, as well as on the impact
on the immunological status of these cells. For this we prepared
PFCE particles with different sizes ranging from 130 nm to
560 nm and incubated them with DC for 19F-labeling. To
determine the impact of the particle size on 19F-labeling and
immunomodulation, we performed MR spectroscopy and a
battery of immunological tests, respectively. Our data show that
the extent of DC 19F-labeling with 1mM PFCE was considerably
improved upon increasing the particle size. At the same time we
also show that an increase in PFCE particle size promotes the
immunogenicity of DC.
Results
Perfluorocarbon particle size determines MR signal
amplitude of DC
Using the direct sonication method we obtained particles with an
average size of 245 nm61.97 nm (6S.E.M.) that increased to
560 nm66.36 nm following steam sterilization. The increase in
particle size was also observed when we prepared PFCE particles
using high pressure homogenization. Although particles doubled in size
following steam sterilization, the size of particles achieved by both
sonication and high pressure homogenization remained constant
over several days under cell culture conditions (data not shown).
Using the 560 nm particles, we labeled DC with different
concentrations of PFCE together with different incubation times.
The 19F signal amplitude was directly proportional to labeling time
and PFCE concentration (Fig. 1A). The area under the curve
(AUC) for DC samples incubated with particles containing 1 mM
PFCE over a period of 3 h, 24 h and 48 h was calculated to be
9.28*107, 1.43*108 and 2.65*108 respectively, while the AUC for
DC samples incubated for 24 h with particles containing 0.4 mM
and 2 mM PFCE was calculated to be 1.18*108 and 2.22*108
respectively. To extrapolate the 19F signal amplitude generated in
vitro to the extent of DC localizing to specific regions in vivo, a
calibration curve was made with different numbers of DC labeled
with the same concentration of 560 nm particles (1 mM PFCE)
and over a period of 24 h. The 19F signal amplitude (Fig. 1B) was
calculated from 19F-MRS using the loop coil for the 9.4T MRI
(Supp. Fig. S1B). The signal achieved was compared with the
cellular in vitro cross-sectional images (FLASH 3D Sequence) of the
19F-labeled cell pellets within the NMR tubes (Fig. 1B, inset) using
a commercial 1H/19F dual-tunable volume birdcage resonator for
the 9.4T MRI (see Methods). The 19F signal amplitude to cell number
curve gave a linear fit indicating that the signal of the spectroscopy
data correlate linearly with the number of labeled cells (Fig. 1B).
With the setup used the minimum amount of labeled cells detectable
in MRS was 0.6*106 DC corresponding to about 1018 fluorine
atoms. For MRI this translates into a minimum cell number of
106 DC within the volume of interest (Fig. 1B). Using the same
concentration of 560 nm particles (1 mM PFCE) we could follow
the migration of 10*106 19F-labeled DC that were loaded with
whole chicken ovalbumin (OVA) antigen. Following 18 h intrader-
mal application of these cells in the right hind limb we observed a
migration of the 19F-labeled cells from footpad into the draining
popliteal lymph node, in contrast to cells that were not loaded with
antigen and applied to the left hind limb (Fig. 1C). In the latter case
the cells remained localized to the footpad.
The size of the PFC particles employed in other recent studies
labeling cells for in vivo MRI tracking ranged from 100 nm to
230 nm [5,9–11]. It is of profound importance to assess the impact
of changes in the particle size on 19F signal amplitude. Hence we
prepared an array of emulsions with different particle sizes ranging
from 130 nm to 560 nm (Table 1). Figure 1D shows that larger
particles with diameters of 365 nm, 480 nm and 560 nm provide
a 19F signal of 5.1*103, 1.3*104 and 1.1*104 arbitrary units,
respectively, in comparison to the smaller particles with diameters
of 130 nm and 150 nm that provide a 19F signal of 4.1*102 and
1.2*103 arbitrary units, respectively. Thus, an increase in particle
size by a factor of approximately 4.3 (130 nm to 560 nm) results in
an increase in signal by a factor of 26.8 (Fig. 1D). Furthermore
the 19F signal appears to reach a plateau with particles larger than
480 nm.
Morphological changes following uptake of
perfluorocarbon particles
Phagocytosis is a major component of the innate immune
system since it is employed by professional antigen presenting cells
(APC) such as DC to internalize particulate targets greater than
500 nm prior to initiation of the adaptive response [13]. Our
initial data indicate that DC, as professional APC, take up larger
particles more readily than smaller particles. Following uptake of
the larger (560 nm) particles we also observed a significant
increase in the granularity of DC, also discerned by an increase in
the sideward light scatter (SSC-A) in FACS (Fig. 2A). Electron
microscopy revealed the fluorine-rich particles as bright smooth
spheroids (Fig. 2B) with a size ranging from about 180 nm to
1500 nm in diameter (average size = 660 nm6280 nm (S.E.M.),
n = 150). Electron microscopy imaging of semithin sections of fixed
DC pellets (Fig. 2B a–b) showed that most of the cells incubated
for 24 h with 1mM PFCE particles (Fig. 2B b) contain clusters of
vesicles in their cytoplasm. Imaging of ultrathin sections (Fig. 2B
c–d) revealed that these vesicles in the nanoparticle-loaded DC
(Fig. 2B d) have a membrane-like surface and an amorphous grey
compartment (see also inset).
Larger perfluorocarbon particles shift DC towards a
mature status
The assessment of the direct impact of PFCE nanoparticles on
the maturation status of DC provided different results for a
spectrum of biomarkers. When we labeled DC with the same
concentration of PFCE (1 mM) we observed a twofold increase in
the surface expression of the co-stimulatory marker CD86 (as
measured by FACS) on DC labeled with particles with a diameter
of 560 nm (Fig. 3A). The increase in CD86 expression was time-
dependent in both bacterial lipopolysaccharide (LPS)-treated and
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untreated (immature) cells (Fig. 3B). The increase in CD86
surface expression was accompanied by a significant increase in
another B7 family member CD80 especially on immature DC
(iDC) that had not been treated with LPS (Fig. 3C). The level of
CD80 achieved following incubation of iDC with PFCE particles
was comparable to that following triggering of Toll-like receptor 4
by LPS. We did not observe any changes in the surface expression
of MHC (H2Kb) (Fig. 3D).
Amplified T cell response by DC incubated with larger
perfluorocarbon particles
CD86 (B7.2) provides the dominant costimulatory signal during
early T cell activation [14]. Indeed an increased expression of
CD86 on DC following treatment with the 560 nm PFCE particles
was accompanied by an increase in priming of antigen-specific T
cells by these DC (Fig. 4A). Naı¨ve CD8+ T cells from C57BL/6-
Tg(OT-I)-RAG1tm1Mom mice primed with DC loaded for 2 h with
OVA peptide, 18 h following 19F labeling (CD86hi), proliferated
significantly better than CD8+ T cells primed with unlabeled DC
(p,0.05) or with DC that had been loaded with OVA peptide 2 h
prior to 19F labeling (p,0.001) (Fig. 4A).
While mature DC may possess an increased capacity to
stimulate T cells upon upregulation of costimulatory markers
such as CD86, they are known to lose their capacity to take up
antigen [15–18]. A recent study using particles larger than 500 nm
also showed that particle size, in contrast to particle shape,
influences phagocytosis completion [19]. Here our results
demonstrate that DC labeled with 560 nm PFCE particles were
less capable to phagocytize dextran as model antigen than
unlabeled DC as shown by FACS staining (Fig. 4B). Dextran-
FITC staining decreased progressively with prolonged labeling
time (Fig. 4B).
Figure 1. Perfluorocarbon particle size determines MR signal amplitude of DC. (A) DC were labeled with different concentrations and
incubation times of 560 nm PFCE particles and their 19F signal was measured in a 3 T MRI scanner using a 90u block excitation pulse with 10 kHz
bandwidth. (B) Different numbers of DC were labeled with 1 mM 560 nm PFCE particles over a period of 24 h and their 19F signal was measured in a
9.4 T MRI scanner. The inset depicts cross-sectional scans of the cell pellets within the NMR tubes made using a FLASH 3D Sequence on the 9.4 T
scanner. (C) DC were labeled with 1 mM 560 nm PFCE particles, loaded with (right) or without (left) antigen and administered intradermally in hind
limb. Shown is a coronal overlay of 19F cellular (red) and 1H anatomical (grayscale) MR images. (D) DC were labeled with different-sized particles and a
constant PFCE concentration (1 mM) and their 19F signal amplitude was measured in a 9.4 T MRI scanner. This experiment is representative of 3
independent experiments
doi:10.1371/journal.pone.0021981.g001
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An upregulation of maturation markers such as CD86 alone
does not necessarily reflect an increased immunogenicity [20].
Considering that the 19F-labeled DC could not phagocytize
optimally (Fig. 4B), we examined the impact of 19F labeling on
the uptake of whole antigen by DC and presentation to T cells. As
shown in Fig. 4C, 19F-labeled DC (brown) could present whole
ovalbumin to and activate B3Z T cells even better than unlabeled
DC when antigen was loaded after 19F labeling: more activated T
cells (blue stain) are visible in this group than in the group
consisting of T cells co-incubated with unlabeled DC or T cells co-
incubated with DC that had been loaded with antigen prior to 19F
labeling (Fig. 4C). The group of B3Z T cells activated by DC
loaded with ovalbumin after 19F labeling secreted significantly
more IL-2 than B3Z T cells that were co-incubated with unlabeled
DC (p,0.001) or DC that had been loaded with ovalbumin prior
to labeling with 19F nanoparticles (p,0.001) (Fig. 4D). These
results together with the increased expression of costimulatory
markers, as well as a decreased capacity of DC to phagocytize,
suggest that the larger (560 nm) fluorine-rich particles do not
obstruct with antigen presentation process but rather promote the
transition of DC towards a mature status. Other than that, the
particles seemed to be well-tolerated as shown by viability tests and
apoptosis assays with AnnexinV/7-amino-actinomycin D (7-AAD)
FACS staining (Supp. Fig. S2).
Discussion
Fluorine MR imaging technology may pave the way towards
clinical diagnostic and molecular/cellular imaging applications,
particularly in immunologically related or driven diseases such as
cancer, infection, autoimmunity or transplantation. Our data
indicate that the larger fluorine-rich particles are taken up more
readily by DC. An increase in particle size (despite a constant
fluorine concentration) significantly enhanced the 19F-labeling of
DC as shown by the increase in fluorine 19F spectral signal.
Although this is favorable especially for the detection and imaging
of smaller numbers of cells in vivo, the larger particles also
precipitate concerns considering the changes in the immunological
status that we observed in DC in this study.
We could show that the larger fluorine-rich particles promote
the maturation process of DC and as a result the priming of naı¨ve
T cells. Notably, we observed that T cells were more actively
primed by DC that were initially labeled with fluorine-rich
particles (prior to peptide loading) than by DC that had been
loaded with OVA peptide alone or OVA peptide (prior to 19F
labeling). In the case of the OVA-specific CD8+ T cell hybridoma,
we even observed a drastic reduction in T cell response when these
cells were treated with DC loaded with full-length ovalbumin prior
to 19F labeling. Future investigations on the timing of antigen-
loading and nanoparticle labeling will help to further uncover
interactions between antigen and 19F particles and the impact of
their interaction on the delivery of stimulatory and costimulatory
signals by DC to antigen-specific T cells.
From the present data, it seems that DC pretreated with
fluorine-rich particles receive a maturation signal (CD86hi) and as
a consequence present peptide more actively to naı¨ve T cells. On
the other hand, we think that DC initially incubated with antigen
are unable to take up PFCE particles due to a down-regulation in
uptake mechanisms. As a result these DC prime naı¨ve T cells
similarly as unlabeled DC and are even unable to activate
antigen-specific responses as shown here with OVA257-264-specific
T cells. A previous report on physicochemical properties of
nanoparticles also demonstrated a skewing of the T cell response:
particles larger than 1 mm induced a Th1 response in vivo,
whereas particles smaller than 500 nm were associated with a
Th2 response [21].
In our present study we presume that–in contrast to smaller
particles (130 nm–365 nm)–the larger (560 nm) particles alter DC
biology by precipitating different uptake mechanisms. Particles
larger than 500 nm are commonly taken up by phagocytosis, in
contrast to particles smaller than 500 nm that are usually taken up
by endocytosis via structures such as caveolae or clathrin-coated
vesicles [22]. However, apart from particle size, it is possible that
other biologically-relevant changes in particle characteristics–such
as shape and surface topology–could also alter DC biology.
Scientists are indeed studying such physics-derived parameters to
deliver solutions for controlling biological responses [23]. It would
therefore be interesting to study the influence of these physical
parameters (by changing surfactant or method of emulsification)
on DC immunogenicity. Such studies are important since any
undesirable modulation of the transplanted immune cells might
pose potential hazards in certain clinical scenarios especially in
those where the immune response should be kept under control
e.g. in autoimmune disease and transplantation medicine. Thus,
depending on the clinical situation in which 19F-labeled cells are
applied it will be important in the future to monitor the fate and
impact of these cells in vivo using the relevant preclinical animal
models. Even for cellular vaccines that are required to enhance the
tumor-specific T cell response in cancer, care should be taken that
the increased immunogenicity by 19F labeling does not precipitate
severe or life-threatening autoimmunity.
Materials and Methods
Preparation of fluorine-rich particles
Particles with high fluorine (19F) content (100 mM–800 mM)
were produced by emulsifying perfluoro-15-crown-5-ether (PFCE,
Table 1. Particles size distribution of different perfluorocarbon emulsions.
Emulsion (particle size) Z-Average Diam. (d.nm) Peak Diam. (nm) Peak Width (nm) PdI
130 nm 130.1 139.0 36.67 0.056
245 nm 243.3 268.8 114.6 0.267
365 nm 367.3 404.7 127.2 0.091
480 nm 477.7 488.8 192.8 0.273
560 nm 565.7 533.4 122.6 0.179
For each emulsion we measured the following physical characteristics of the particles by using dynamic light scattering: Z-average diameter (mean diameter based on
intensity of scattered light and sensitive to presence of large particles), peak diameter, peak width and polydispersity index (PdI) that gives a quantitative estimation of
the particle size distribution.
doi:10.1371/journal.pone.0021981.t001
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Fluorochem, Derbyshire, UK), a chemically and biologically inert
macrocycle consisting of 20 chemically equivalent fluorine (19F)
nuclei, leading to only one signal in NMR spectra, which is
important for quantification. PFCE was emulsified using Pluronic
F-68 (Sigma-Aldrich, Germany) as emulsifying agent and by direct
sonication with a cell disrupting titanium sonotrode (Bandelin
Sonopuls GM70, Bandelin, Berlin, Germany). With this sonotrode
we emulsified 200 mM PFCE in Pluronic F-68 by employing a
continuous pulse program for 60 sec. Alternatively, an ultrasonic
device connected to a block (VialTweeter, Hielscher Ultrasonics
GmbH, Teltow, Germany) was used for indirect and more intense
sonication of microtubes (1500 ml or 2000 ml) to reach the lower
particle sizes. Different particle sizes were achieved by altering the
sonication time and by changing the concentration of PFCE. We
also employed high pressure homogenization (MicrofluidizerH M-110S,
Microfluidics, MA, USA) as an alternate method for emulsifica-
tion, using pressures of up to 160 MPa. However, in contrast to
the sonication method, high pressure homogenization required a
minimum of 14 ml total volume for emulsification and sample
losses of c. 10% were inevitable due to dead space. The average
particle diameter was determined by dynamic light scattering
using a Malvern Zetasizer Nano ZS instrument (Malvern
Instruments, Worcestershire, UK). The physical characteristics
of the particles generated with each new emulsion was
documented and is shown in Table 1. Using both direct and
indirect sonication systems it was possible to obtain particles with
different sizes ranging from 130 nm to 560 nm. By autoclaving,
particles generated by both sonication and high pressure homogenization
increased to approximately double the original size. Since we
employed these particles for DC immunological studies we tested
endotoxin levels within all emulsions produced using the portable
EndosafeH-PTSTM (Charles River, Germany). We did not detect
any endotoxins at a test sensitivity of 0.1 EU/ml.
Generation of mouse bone-marrow (BM)-derived DC
DC were prepared from BM suspensions as previously
described [24]. Briefly, BM from femurs of C57BL/6 mice were
grown in RPMI-1640 medium containing 10% FCS (Biochrom,
Germany) and supplemented with 10 ng/ml GM-CSF. For the
analysis of maturation markers, cells were matured by incubating
with 1 mg/ml lipopolysaccharide (LPS) for 24 h.
In vitro MR-measurements
DC (3*106) were labeled with emulsions containing different PFCE
concentrations (0.4 mM, 1 mM, 2 mM), different particle sizes
(130 nm–560 nm) and using different incubation times (3 h, 24,
48 h). Thereafter DC were thoroughly washed and fixed in 2% PFA.
19F uptake within fixed cells was monitored by 19F spectroscopy. Two
separate 19F tuned loop coils (Supp. Fig. S1A, 1B) were designed for
signal transmission and reception on a 3 Tesla (3 T) human MRI
scanner (MedSpec 30/100, Bruker, Ettlingen, Germany) and a 9.4 T
animal MRI scanner (Biospec 94/20-USR, Bruker, Ettlingen,
Germany). The 19F signal was acquired using a 90u block excitation
pulse with 10 kHz bandwidth and the amplitude was calculated by
performing a fast Fourier transformation (FFT) of the acquired free
induction decay (FID). Alternatively, the area under the curve (AUC)
of the spectra was calculated. For comparison, 19F baseline MR
spectra were acquired prior to labeling.
In vivo MR-measurements
Animal experiments were carried out in accordance with the
guidelines provided and approved by the Animal Welfare
Department of the LAGeSo State Office of Health and Social
Affairs Berlin (Permit G0070/09: Migration v. Immunzelltherapien,
15.07.2009-31.07.2012). Prior to in vivo application, DC were
incubated for 24 h with 19F emulsion (using a concentration of
1 mM perfluoro-15-crown-5-ether and 560 nm particle size) and
Figure 2. Perfluorocarbon particles increase DC granularity. (A) Forward and sideward scatter of unlabeled versus 19F-labeled DC as
determined by FACS analysis. (B) Electron microscopy of DC pellets embedded in Poly/Bed 812 (see Methods). Morphology of DC in semithin (a,b)
sections (x 100, bar = 20 mm) and ultrathin (c,d) sections (x 11 000, bar = 1 mm, inset622 000). Arrowheads indicate vesicles with a membrane-like
surface and an amorphous grey compartment.
doi:10.1371/journal.pone.0021981.g002
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6 h with 5 mg/ml full-length chicken EndoGrade ovalbumin
(endotoxin conc.,1 EU/mg; Hyglos, Regensburg, Germany).
Thereafter, DC were harvested, washed thoroughly in serum-free
buffer, administered intradermally (3–10*106) into the left hind limb
of C57BL/6 mice and imaged 18 h following injection. Shortly
before and during the MR session, mice were anesthetized using a
mixture of isoflurane as inhalation narcosis (0.5–1.5%), pressurized
air and oxygen. Mice were imaged on the 9.4 T animal MRI using
a custom made 1H/19F dual-tunable volume birdcage resonator
(Rapid Biomed, Wu¨rzburg, Germany) with 35 mm inner diameter
and 50 mm length. The temperature of the mice was regulated at
37uC. The breathing rate and temperature was monitored by a
remote monitoring system (Model 1025, SA Instruments Inc., New
York, USA). Images were acquired using a 3D-FLASH gradient-
echo sequence. For 19F imaging, TR = 8 ms; TE = 3 ms; flip
angle = 10u; FOV = 50625625 mm, matrix = 20061006100;
number of averages = 80. For 1H imaging, TR = 11 ms; TE = 4 ms;
flip angle = 15u; FOV = 50625625 mm; matrix = 40062006200,
number of averages = 8. For both in vivo and in vitro MR-
measurements a Redhat RHEL4 system and Paravision v5 (Bruker
Biospin, Ettlingen, Germany) software were used.
Electron microscopy
Cells were fixed for 24 hours in PBS containing 2% glutaralde-
hyde and postfixed for 2 h with 1% osmium tetroxide. Cell pellets
were then dehydrated in an ascending series of ethanol and
embedded in Poly/Bed 812 (Polysciences, Eppelheim, Germany).
Semithin sections of the DC pellets were stained with toluidine blue.
Ultrathin sections were stained with uranyl acetate and lead citrate.
Sections were imaged using a FEI Morgagni electron microscope
(FEI, Eindhoven, The Netherlands) and iTEM software.
Annexin/7-AAD assay
Harvested iDC were washed with ice cold PBS and resuspended
in binding buffer (10 mM Hepes, pH 7.4, 140 mM NaCl, 2.5 mM
CaCl2). Thereafter, 10
5 cells were incubated with 7-amino-
actinomycin D (7-AAD) and PE-conjugated annexinV (BD
Biosciences, Heidelberg, Germany), and then analyzed by FACS
using a FACSCanto II flow cytometer equipped with FACSDiva
software (BD Biosciences, Heidelberg, Germany). The percentages
of AnnexinV-/7-AAD-, AnnexinV+/7-AAD-, and AnnexinV+/7-
AAD+ populations were calculated corresponding to the distribu-
tion in the set quadrants.
Figure 3. Larger perfluorocarbon particles shift DC towards a mature status. (A) Immature DC were labeled with different sizes of 1 mM
PFCE particles. The surface CD86 expression (geometric mean stained samples–geometric mean unstained controls) was determined by FACS analysis. (B)
Immature and LPS-matured DC were labeled with 1 mM PFCE particles (560 nm). The surface CD86, CD80 (C) and MHC/H2Kb (D) expression was
determined as in A. Each figure represents the results of 3 grouped experiments.
doi:10.1371/journal.pone.0021981.g003
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Surface staining of costimulatory molecules and MHC-I
To determine the maturation status, DC were washed with
FACS buffer, stained with anti-CD80, anti-CD86 and MHC-I
(H2Kb) antibodies and analyzed by FACS using a FACSCanto II
and FACSDiva software (BD Biosciences, Heidelberg, Germany).
T cell priming
Naı¨ve CD8+ T cells (CD8+CD44-CD62L+) were sorted from
spleen and LN cells of C57BL/6-Tg(OT-I)-RAG1tm1Mom mice
(Taconic, Lille Skensved, Denmark) using FACS sorting (FAC-
SAria, BD Biosciences). Tg(OT-I)-RAG1tm1Mom mice are homozy-
gous for a transgene encoding, a T cell receptor specific for
OVA257–264 presented by the MHC class I molecule H-2Kb. iDC
were incubated for 2 h with 10 mg/ml ovalbumin peptide
(OVA257–264) and thereafter incubated with sorted naı¨ve CD8
+
T cells. T cell proliferation (as a measure of T cell priming) was
determined 3 d later using a 3H thymidine incorporation assay (see
below). For experiments where DC were labeled with PFCE
particles, OVA peptide was given either prior to or following
PFCE labeling: iDC were either incubated for 18 h with PFCE
particles and thereafter for an additional 2 h with OVA257–264
prior to incubation with naı¨ve T cells (DC–OVA peptide after
19F), or alternatively incubated for 2 h OVA257–264 and thereafter
18 h with PFCE particles prior to incubation with naı¨ve T cells
(DC–OVA peptide before 19F).
3H thymidine incorporation proliferation assay
[3H]thymidine (0.5 mCi) (Amersham Biosciences, Freiburg,
Germany) was added to each well of a proliferation assay plate.
Incorporation of radioactivity was measured after 18 h with a
TopCount NXT beta counter (PerkinElmer LAS GmbH,
Rodgau-Ju¨gesheim, Germany).
Figure 4. Larger perfluorocarbon particles hinder DC phagocytic activity but promote T cell response. (A) DC were incubated with/
without 19F particles (560 nm) and ovalbumin (OVA) peptide and then co-incubated with naı¨ve CD8+ T cells (CD8+CD44-CD62L+). Shown is the
proliferation of CD8+ T cells measured in cpm (counts per minute) using a standard 3H-thymidine incorporation assay. This experiment is
representative of 3 independent experiments. (B) DC were incubated with 19F particles (560 nm) over a period of time and their phagocytic capacity
measured using a FITC-dextran incorporation assay. The fluorescence intensity of FITC-dextran in CD11c+ DC was measured by FACS analysis. This
experiment is representative of 4 independent experiments. (C) DC were incubated with 19F particles (560 nm) and full-length endotoxin-free
ovalbumin. Thereafter DC were co-incubated with B3Z T cells. Shown is an X-Gal staining of activated, b-galactosidase expressing (blue) B3Z T cells.
This experiment is representative of 2 independent experiments. (D) DC were treated with 19F particles and full-length ovalbumin, thereafter co-
incubated with B3Z T cells as in C. To quantify T cell activation, the amount of soluble IL-2 in the cell culture supernatants was measured by ELISA.
This experiment is representative of 3 independent experiments.
doi:10.1371/journal.pone.0021981.g004
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FITC-dextran incorporation assay
iDC (16105) were resuspended in 100 ml PBS and incubated
with 1 mg/ml FITC-dextran (Sigma-Aldrich Chemie, Schnell-
dorf, Germany) at 37uC and 0uC (negative control) for 30 min.
The incubations were stopped by adding 2 ml of ice-cold PBS
containing 1% serum and 0.02% sodium azide. After thorough
washing, cells were analyzed by FACS (FACSCanto II).
Appropriate gates were made on viable CD11c+ cells to exclude
debris and dead cells.
Activation of B3Z cells
DC were loaded with 5 mg/ml full-length chicken EndoGrade
ovalbumin (endotoxin conc.,1 EU/mg; Hyglos, Regensburg,
Germany) for 18 h and thereafter co-incubated with B3Z cells
that express a TCR specifically recognizing OVA257–264 and carry
a b-galactosidase (lacZ) construct driven by nuclear factor of
activated T cells elements from the IL-2 promoter [25]. For
experiments where DC were labeled with PFCE particles, full-
length ovalbumin was given either prior to or following PFCE
labeling as described above (T cell priming) for OVA257–264 peptide
loaded DC. To determine the activation status of B3Z T cells,
intracellular b-galactosidase activity was measured by X-Gal
staining as previously described [26]. Briefly, cells were fixed in
0.05% glutaraldehyde and incubated for 24 h at 37uC in X-Gal
staining solution.
Measurement of soluble IL-2
Supernatants were collected 24 h following co-culturing DC
with B3Z cells and stored at 280uC. Soluble IL-2 was measured
by ELISA following the company’s instructions (eBioscience,
NatuTec, Frankfurt, Germany).
Statistics
Statistical analysis was performed with SPSS 12 (SPSS Inc.,
Chicago, IL, USA). For group comparisons, the t-test was used *:
p-value,0.05, **,0.01, ***,0,001. Graphical presentation was
done with SigmaPlot 10 (Systat Software, Germany), Excel H 2007
(Microsoft H Office) and Gnuplot v4.2.6 by T. Williams and C.
Kelly (http://www.gnuplot.info/). All data presented in the bar
graphs indicate the mean and the standard error of the mean
(S.E.M.).
Supporting Information
Figure S1 Design of 19F loop coils for 19F-MRS. (A) Loop
coil (5-turn) that holds NMR-tubes for measuring 19F signal in cell
pellets using a human 3 T scanner (B) Loop coil (4-turn) for
measurement of 19F-labeled cells in NMR-tubes using an animal
9.4 T scanner.
(TIF)
Figure S2 Perfluorocarbon particles are well tolerated
by DC. DC were incubated with PFCE particles (560 nm) over a
period of 3 days after which cells were stained with AnnexinV-PE
and 7-AAD and measured by FACS. Depicted in each quadrant is
the percentage of cell populations in different conditions: viable
(LL, AnnexinV-, 7-AAD-), early apoptotic (LR, AnnexinV+, 7-
AAD-), late apoptotic or dead (UR, AnnexinV+/7-AAD+), dead
(UL, AnnexinV-, 7-AAD+).
(TIF)
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